Last week’s regulatory news saw the US Food and Drug Administration (FDA) grant accelerated approval for AstraZeneca’s ...
The US Food and Drug Administration (FDA) has approved Dutch biopharma firm Pharming’s (supplemental New Drug Application ...
US biotech company Encoded Therapeutics has closed a $275 million series F financing that will fund pivotal testing of ETX101 ...
The Medicare Drug Price Negotiation Program is now running three cycles at once. Negotiated prices for the first ten products ...
Japanese drugmaker Takeda has announced that Andy Plump, president of research and development and a member of its board of ...
Three documents now define how the two largest medicines regulators think about artificial intelligence in drug development.
New peer-reviewed data published in The Lancet Infectious Diseases report results from a Phase III study of 7,699 adults aged ...
Family-controlled Italian drugmaker Chiesi Group today announced its financial results for the six months ended June 30, 2026 ...
US pharma major AbbVie announced positive top-line results from the Phase III LUNA study, which evaluated Qulipta (atogepant) ...
Swiss pharma major Novartis (NOVN: VX) is under public pressure to overhaul its board after two late-stage trial failures in ...
Adneuris Therapeutics, a wholly owned subsidiary of Tris Pharma advancing a new kind of pain medicine, has announced novel ...
Pharma industry leaders at Phacilitate Advanced Therapies Europe (ATE) 2026 have this week warned that Europe must address persistent barriers to commercialization, reimbursement, manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results